dc.creator | Munin J. | |
dc.creator | Quezada E. | |
dc.creator | Viña D. | |
dc.creator | Uriarte E. | |
dc.creator | Delogu G.L. | |
dc.creator | Gil-Longo J. | |
dc.date.accessioned | 2020-09-02T22:23:45Z | |
dc.date.accessioned | 2022-11-08T20:23:03Z | |
dc.date.available | 2020-09-02T22:23:45Z | |
dc.date.available | 2022-11-08T20:23:03Z | |
dc.date.created | 2020-09-02T22:23:45Z | |
dc.date.issued | 2019 | |
dc.identifier | 11, 3, 179-191 | |
dc.identifier | 17568919 | |
dc.identifier | https://hdl.handle.net/20.500.12728/5469 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5144674 | |
dc.language | en | |
dc.publisher | Future Medicine Ltd. | |
dc.subject | calcium channel blockers | |
dc.subject | endothelium | |
dc.subject | phthalazinone derivatives | |
dc.subject | rat aortic rings | |
dc.subject | synthesis | |
dc.subject | vasorelaxant activity | |
dc.subject | 2 (2 aminoethyl) 4 (3',5' dimethoxybenzyl) 2h phthalazin 1 one | |
dc.subject | 2 (aminoalkyl) 4 benzyl 2h phthalazin 1 one derivative | |
dc.subject | caffeine | |
dc.subject | calcium channel | |
dc.subject | calcium chloride | |
dc.subject | hydralazine | |
dc.subject | ionomycin | |
dc.subject | phenylephrine | |
dc.subject | phthalazinone derivative | |
dc.subject | potassium chloride | |
dc.subject | unclassified drug | |
dc.subject | vasodilator agent | |
dc.subject | aorta | |
dc.subject | Article | |
dc.subject | concentration response | |
dc.subject | controlled study | |
dc.subject | drug activity | |
dc.subject | drug development | |
dc.subject | drug synthesis | |
dc.subject | priority journal | |
dc.subject | vasodilatation | |
dc.title | Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels | |
dc.type | Article | |